TOFUTTI BRANDS INC

TOFB
About the company

Tofutti Brands Inc. engages in the development, production, and marketing of plant-based, dairy-free cheese, and dessert products in the United States, Europe, the Middle East, the Asia Pacific, and Africa. The company offers dairy-free vegan cheese products, such as BETTER THAN CREAM CHEESE, which is similar in taste and texture to traditional cream cheese; TOFUTTI WHIPPED BETTER THAN CREAM CHEESE; sour cream under the BETTER THAN SOUR CREAM brand; and TOFUTTI AMERICAN VEGAN CHEESE SLICES, a vegan alternative to regular cheese slices.

Country: United StatesPrice: $0.30Market Cap: $1.5M

Investment snapshot

12%positive consensus
Scored 1d ago

Positive

2

BUY / PASS

Neutral / negative

2 / 12

NEUTRAL / FAIL

Median fair value

$0.32

+6.7% vs price

Models with upside

1 / 17

Positive margin of safety

Strongest signal

8 of 12 pass — Graham, Buffett, Lynch +1 more object

Key risk

No clean pass — all 13 investors flag at least one valuation criterion

Framework analysis

VerdictMeaning
BUYPositive purchase signal: the framework's buy requirements are met.
PASSThe company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state.
NEUTRALNeither a positive nor negative conclusion. It does not mean to hold an existing position.
FAILThe company does not clear the framework's requirements.
RankedRanked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL.

Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.

MetricGraham

Defensive Value

Buffett

Quality Compounder

Lynch

GARP

Greenblatt

Magic Formula

Piotroski

F-Score

Dreman

Contrarian Value

Munger

Quality Focus

Pabrai

Dhandho Framework

Akre

Three-Legged Stool

Marks

Risk-Aware Value

Ackman

Activist Value

Templeton

Global Bargain Hunter

Sleep

Scale Economies Shared

Asness

Systematic Factors

Neff

Low-P/E Total Return

Schloss

Asset-Value Discipline

O'Shaughnessy

Systematic Factor Composite

VerdictFAILFAILFAILNot rankedPASSFAILFAILFAILFAILFAILFAILPASSFAILFAILFAILNEUTRALNEUTRAL
Score
AnalysisChecking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…
Intrinsic Value (annual)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Margin of SafetyN/AN/AN/AN/AN/AN/AN/AN/A+6.2%N/AN/AN/AN/AN/AN/AN/AN/A
Financial Basis

TTM ended 2026-09-26 · Balance sheet at 2026-09-26 · Annual history · FY 2025

Latest source filing: 2026-11-10

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-04-13

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-26

Latest source filing: 2026-11-10

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-04-13

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-04-13

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-26 · Balance sheet at 2026-09-26 · Market data at 2026-11-01

Latest source filing: 2026-11-10

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025

Latest source filing: 2026-04-13

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025

Latest source filing: 2026-04-13

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-04-13

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-04-13

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-26 · Market data at 2026-11-01

Latest source filing: 2026-11-10

Score computed: 2026-11-14

Annual history · FY 2025 · Price history 2025-01-01–2026-11-01

Latest source filing: 2026-04-13

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-04-13

Score computed: 2026-11-14

TTM ended 2026-09-26 · Balance sheet at 2026-09-26 · Price history 2025-01-01–2026-11-01 · Annual history · FY 2025

Latest source filing: 2026-11-10

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-04-13

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-09-26

Latest source filing: 2026-11-10

Score computed: 2026-11-14

TTM ended 2026-09-26 · Annual history · FY 2025 · Price history 2025-01-01–2026-11-01

Latest source filing: 2026-11-10

Score computed: 2026-11-14

Where It Passes

  • Debt & Leverage67% pass✓ 11✗ 4▾

    8 of 12 pass — Graham, Buffett, Lynch +1 more object

    LT Debt vs Net Current Assets
    ✗GrahamLT Debt <= Net Current Assets
    Debt/Equity & Interest CoverageD/E: 0.00, IC: -773.0x
    ✗BuffettD/E < 0.5 AND Interest Coverage > 5x
    Total Debt / Equity0
    ✓Lynch< 0.33
    Cash - Long-term Debt
    ✗LynchPositive preferred
    LT Debt / Total Assets Change0.00% -> 0.00%
    ✓PiotroskiDecreased YoY
    Current Assets / Current Liabilities3.46
    ✓Dreman> 1.5✓SchlossCurrent ratio >= 1.50x (app cutoff)
    Total Debt / Shareholders' Equity0
    ✓Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00x
    Debt Levels0
    ✓MungerDebt/Equity < 0.5✓AkreDebt/Equity < 0.3
    Interest Coverage & Debt/EBITDAIC=-773.0x, D/EBITDA=N/A (D&A unavailable)
    ✗MarksInterest Coverage > 3x; Debt/EBITDA < 4x
    Total Debt / Shareholders Equity0
    ✓Ackman<= 1.0
    Negative debt-to-equity (higher means less debt)-0.0027; #439/4210 (top 10.4%)
    ✓AsnessTop 30% of eligible cross-section

Where It Falls Short

  • Valuation0% pass✓ 8✗ 20▾

    No clean pass — all 13 investors flag at least one valuation criterion

    Price / 3-yr avg EPS
    ✗Graham<= 15x
    Price-to-Book Ratio0.7x
    ✓Graham<= 1.5x
    P/E x P/B
    ✗Graham<= 22.5
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    EBIT / Enterprise Value-64.1%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=-64.1%, ROC=None
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Price / EPS
    ✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)
    Price / (CFO / Shares)N/A (negative CFPS)
    ✗Dreman< 8x
    Price / Book Value per Share0.7x
    ✓Dreman< 1.2x✓Templeton< 1.5x✓SchlossP/B <= 0.80x (app cutoff)
    Valuation Reasonableness
    ✗MungerP/E < 25 or Owner Earnings Yield > 5%
    P/E or FCF Yield
    ✗PabraiP/E < 15 or FCF Yield > 10%
    P/B or P/E vs. Historical AverageP/B=0.7x
    ✓MarksP/E < 15 or P/B < 2.0
    Discount to Intrinsic ValueN/A (negative normalized EPS)
    ✗Marks>= 20% below intrinsic value
    Price / FCF per Share
    ✗Ackman<= 25
    Price vs. Trailing Low100% of trailing low ($0.30)
    ✓Templeton<= 120% of trailing low (certified split-adjusted live window)
    Net income / market capitalization-55.43%; #5103/6340 (top 80.5%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Positive book equity / market capitalization+1.1791; #1228/6449 (top 19.0%)
    ✓AsnessTop 30% of eligible cross-section
    Price / Diluted EPS
    ✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)
    (EPS CAGR % + Dividend Yield %) / P/E
    ✗Neff> 0.7 (Neff's published traditional edge)
    Price / Tangible Book Value per Share0.70x
    ✓SchlossP/TBV <= 1.00x (app cutoff)
    Book Value per Share Change-50.1%
    ✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)
    Revenue / market capitalization+4.4162; #601/5247 (top 11.5%)
    ✗OshaughnessyTop 10% of eligible cross-section
    (Operating cash flow - capex) / market capitalization
    ✗OshaughnessyTop 10% of eligible cross-section
    Trailing six-month price return through the evaluation date-61.04%; #5418/6202 (top 87.4%)
    ✗OshaughnessyTop 10% of eligible cross-section
  • Cash Flow0% pass✓ 1✗ 11▾

    No clean pass — all 10 investors flag at least one cash flow criterion

    Free Cash Flow Proxy
    ✗BuffettPositive and growing
    FCF Positive and Growing$-0.0M
    ✗LynchPositive and growing
    Operating Cash Flow$-0.1M
    ✗PiotroskiCFO > 0
    (CFO / Total Assets) vs ROACFO/Assets=-2.90%, ROA=-22.99%
    ✓PiotroskiCFO/Assets > ROA
    Price / (CFO / Shares)N/A (negative CFPS)
    ✗Dreman< 8x
    P/E or FCF Yield
    ✗PabraiP/E < 15 or FCF Yield > 10%
    FCF Positive0/2 years FCF positive
    ✗MarksPositive FCF in majority of recent years
    (OCF - CapEx) / Market Cap
    ✗Ackman>= 4%
    Price / FCF per Share
    ✗Ackman<= 25
    Positive Operating Cash Flow frequency5/16 years positive
    ✗SleepPositive OCF in >= 70% of available years
    Operating Cash Flow - Capital Expenditures
    ✗Neff> $0 (app proxy for a strong fundamental case)
    (Operating cash flow - capex) / market capitalization
    ✗OshaughnessyTop 10% of eligible cross-section
  • Profitability6% pass✓ 5✗ 30▾

    15 of 16 flag TOFB's profitability — Graham, Buffett, Lynch +12 more

    Positive EPS (10 years)8/19 years positive
    ✗GrahamPositive EPS every year for 10 years
    EPS Growth (3-yr avg, 10-yr window)
    ✗Graham>= 33% growth
    Net Income Positive (10+ years)10/19 years positive
    ✗BuffettPositive every year for 10+ years
    ROE (up to 5-year arithmetic mean)-16.7%
    ✗Buffett> 15% arithmetic mean (app rule)
    Operating Margin (10-yr trend)-9.9% (latest)
    ✗BuffettStable or rising over 10 years
    Free Cash Flow Proxy
    ✗BuffettPositive and growing
    Earnings Variance (10-yr CoV)N/A (negative mean EPS)
    ✗BuffettCoV < 0.3
    Retained Earnings Effectiveness
    ✗Buffett$1 retained -> > $1 market value created
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    ROE-47.0%
    ✗Lynch> 15%
    EBIT / Enterprise Value-64.1%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=-64.1%, ROC=None
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Net Income / Total Assets-22.99%
    ✗PiotroskiROA > 0
    ROA Change YoY-22.50% -> -22.99% (delta: -0.50%)
    ✗PiotroskiCurrent ROA > Prior ROA
    (CFO / Total Assets) vs ROACFO/Assets=-2.90%, ROA=-22.99%
    ✓PiotroskiCFO/Assets > ROA
    Gross Margin Change YoY25.5% -> 26.3%
    ✓PiotroskiImproved YoY
    Pre-Tax Income / Revenue-12.8%
    ✗Dreman>= 8%
    Net Income / Shareholders' Equity-47.0%
    ✗Dreman> 12%
    Margin of SafetyP/B=0.7x
    ✓PabraiP/B < 1.5 or P/E < 15
    Return on Equity-24.6% (3-yr avg)
    ✗AkreROE > 20% (3-year avg)
    Discount to Intrinsic ValueN/A (negative normalized EPS)
    ✗Marks>= 20% below intrinsic value
    Positive Net Income Frequency10/18 years positive
    ✓MarksPositive net income in >= 7 of last 10 years
    Operating Income / Revenue-9.9%
    ✗Ackman>= 15%
    Net Income / Shareholders Equity-47.0%
    ✗Ackman>= 15%
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Operating Margin Trend-2.4% (2023) -> -9.9% (2025)
    ✗TempletonNon-negative operating-margin trend over 3 years
    Revenue growth vs. gross and operating margin trendgross margin 27.8% -> 26.3%, operating margin -2.4% -> -9.9%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    Net income / market capitalization-55.43%; #5103/6340 (top 80.5%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Gross profit / total assets+67.43%; #372/3702 (top 10.0%)
    ✓AsnessTop 30% of eligible cross-section
    Net income / positive book equity-47.01%; #4168/5226 (top 79.8%)
    ✗AsnessTop 30% of eligible cross-section
    Negative 5-year standard deviation of ROA-0.0969; #3430/5884 (top 58.3%)
    ✗AsnessTop 30% of eligible cross-section
    3-5 Year Diluted EPS CAGR-17.8% over 5 years
    ✗Neff7%-20% annualized
    Positive Diluted-EPS Years6/10 years positive
    ✗Schloss>= 70% positive over 5-10 observed years (app rule)
  • Growth13% pass✓ 1✗ 12▾

    7 of 8 flag TOFB's growth — Graham, Lynch, Dreman +4 more

    EPS Growth (3-yr avg, 10-yr window)
    ✗Graham>= 33% growth
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    Inventory Growth vs Revenue GrowthInv: -8.0% vs Rev: -11.8%
    ✗LynchInventory growth < Revenue growth
    EPS Growth Direction$0.09 (2010) -> $-0.15 (2025)
    ✗DremanPositive over recent years
    EPS CAGR-9.5% CAGR over 11 years
    ✗Dreman> 5% annualized
    Positive Net Income Frequency10/18 years positive
    ✓MarksPositive net income in >= 7 of last 10 years
    3yr Median Revenue Growth-12.4%
    ✗Ackman>= 5%
    Positive EPS Growth Frequency2/5 years with positive EPS growth
    ✗AckmanPositive EPS growth in >= 3 of last 5 years
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Revenue growth vs. gross and operating margin trendgross margin 27.8% -> 26.3%, operating margin -2.4% -> -9.9%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    5-year Revenue CAGR-10.9%
    ✗SleepCAGR > 7%
    3-5 Year Diluted EPS CAGR-17.8% over 5 years
    ✗Neff7%-20% annualized
  • Verdicts14% pass✓ 2✗ 12▾

    Split decision: 12 FAIL · 2 PASS · 2 NEUTRAL

    Overall verdict
    ✗GrahamFAIL (2/9)✗BuffettFAIL (0/9)✗LynchFAIL (1/7)•GreenblattNot ranked✓PiotroskiPASS (F-Score 4)✗DremanFAIL (3/11)✗MungerFAIL (1/4)✗PabraiFAIL (1/3)✗AkreFAIL (1/6)✗MarksFAIL (2/5)✗AckmanFAIL (2/9)✓TempletonPASS (4/8)✗SleepFAIL (1/6)✗AsnessFAIL (Rank #1608/2370 (Top 67.8%))✗NeffFAIL (0/6)•SchlossNEUTRAL (4/7)•OshaughnessyNEUTRAL (Not ranked)
  • Efficiency25% pass✓ 2✗ 9▾

    6 of 8 flag TOFB's efficiency — Buffett, Greenblatt, Piotroski +3 more

    Current Ratio3.46
    ✓Graham>= 2.0
    ROIC (3-5 yr avg)-15.0%
    ✗Buffett> 10%
    ROIC - WACC-25.0%
    ✗BuffettPositive (WACC = 10%)
    EBIT / (NWC + Net Fixed Assets)
    ✗Greenblatt> 25%
    Current Ratio Change YoY6.28 -> 3.22
    ✗PiotroskiIncreased YoY
    Revenue / Total Assets Change YoY2.31x -> 2.30x
    ✗PiotroskiImproved YoY
    Current Assets / Current Liabilities3.46
    ✓Dreman> 1.5
    Return on Invested Capital-27.6%
    ✗Munger> 15%
    ROIC (high and growing)FY2023: ROIC=-4.9%; FY2024: ROIC=-15.9%; FY2025: ROIC=-27.6%
    ✗AkreLatest 3 consecutive FYs: ROIC > 15% in each
    Reinvestment Rate x ROICN/A (non-positive net income)
    ✗AkreReinvestment Rate * ROIC > 10%
    ROIC (5-year)0/5 years above 12% (latest -27.6%)
    ✗SleepROIC > 12% in a majority of years

Business & financials

Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.

Company Profile

Industry: Food Products
Size: Micro Cap($1.5M)
Revenue: $7.8M-11.8% YoY
Net Income: $-778000.00+9.5% YoY

Financial Snapshot

Operating Margin-9.9%
Return on Equity-35.2%
Debt / Equity0.00
Current Ratio3.22
EPS (Diluted)$-0.15
Shares Retired0.0% / 0.0% 2y

Similar Companies

MDLZMondelez International, Inc.
$85.5B
ADMArcher-Daniels-Midland Co
$34.7B
TSNTYSON FOODS, INC.
$20.7B
GISGENERAL MILLS INC
$18.4B

Shareholder Return

Fiscal 2025

Retired 0.0% of shares last year, 0.0% over two.

Buybacks
—
Dividends
—

Company Financials

Latest TTM and quarters alongside annual years

TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.

The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.

MetricTTM · 2026-09-26

2025-09-28 – 2026-09-26

Sources · derived quarter values

Derived from cumulative filings: revenue, net income, operating income, gross profit, ebit, pre tax income, interest expense, operating cash flow.

Q3 FY 2026

2026-06-28 – 2026-09-26

Sources · derived quarter values

Derived from cumulative filings: interest expense, operating cash flow.

Q2 FY 2026

2026-03-29 – 2026-06-27

Sources · derived quarter values

Derived from cumulative filings: interest expense, operating cash flow.

Q1 FY 2026

2025-12-28 – 2026-03-28

Sources
FY 2025
Sources
  • 10-K · 2026-04-13
FY 2024
Sources
  • 10-K/A · 2025-03-31
FY 2023
Sources
  • 10-K · 2024-04-03
FY 2022
Sources
  • 10-K · 2023-03-31
FY 2021
Sources
  • 10-K · 2022-04-01
Market Cap$1.5Mcurrent------$4.2Mest.$3.4Mest.$4.5Mest.$6.1Mest.$12.6Mest.
Revenue$6.8M$1.2M↓35%$1.8M↓12%$1.6M↓2%$7.8M↓12%$8.8M↓12%$10.1M↓22%$12.8M↑2%$12.6M
Operating Income-------$253.0K↓57%-$773.0K↓27%-$607.0K↓155%-$238.0K↑74%-$916.0K↓479%$242.0K
Net Income-$857.0K-$12.0K↑91%-$118.0K↓1586%-$255.0K↓57%-$778.0K↑10%-$860.0K↓135%-$366.0K↑30%-$525.0K↓467%$143.0K
EPS (Diluted)--$0.00↑100%$-0.02$-0.05↓67%$-0.15↑12%$-0.17↓143%$-0.07↑30%$-0.10↓433%$0.03
Gross Margin26.6%46.4%↑71%25.4%↓17%30.1%↓19%26.3%↑3%25.5%↓8%27.8%↑52%18.3%↓31%26.5%
Operating Margin———-16.2%↓61%-9.9%↓44%-6.9%↓191%-2.4%↑67%-7.1%↓472%1.9%
ROE-47.0%———-35.2%↓22%-28.8%↓198%-9.7%↑25%-12.8%↓509%3.1%
Total Debt------$1.0K↓94%$6.0K↓73%$22.0K↓42%$38.0K↓30%$54.0K↓67%$165.0K
Shareholders' Equity$1.8M$1.8M↓32%$1.8M↓35%$2.0M↓31%$2.2M↓26%$3.0M↓21%$3.8M↓7%$4.1M↓10%$4.6M
Current Ratio3.463.46↑6%3.37↓37%2.92↓44%3.22↓49%6.28↑18%5.34↑41%3.80↓48%7.36
Debt / Equity———0.00↓92%0.00↓63%0.01↓26%0.01↓24%0.01↓64%0.04
Operating Cash Flow-$475.0K$15.0K↓95%$61.0K↑124%-$279.0K↓289%-$98.0K↑73%-$358.0K↓59%-$225.0K↑63%-$616.0K↓189%$689.0K
Free Cash Flow------------------

Score history

Historical Score Timeline

Industry peers

Industry Peers

Similar companies in Food Products

TOFB vs Peers — Financial Grading

Revenue$7.8MBottom 25%
Net Income$-778000.00Bottom 25%
ROE-35.2%Bottom 25%
D/E0.00Top 25%
Op. Margin-9.9%Bottom 25%
Curr. Ratio3.22Top 25%
CompanyMarket CapPriceRevenueNet IncomeROED/EOp. MarginCurr. RatioGrahamBuffettLynchGreenblattPiotroskiDreman
Mondelez International, Inc.MDLZ$85.5B$67.54$38.5B$2.5B9.5%0.729.2%0.592/93/93/70/3F-Score 64/11
Archer-Daniels-Midland CoADM$34.7B$72.90$80.3B$1.1B4.7%0.33—1.375/92/91/70/3F-Score 55/11
TYSON FOODS, INC.TSN$20.7B$58.82$54.4B$474.0M2.6%0.492.0%1.553/92/90/70/3F-Score 53/11
GENERAL MILLS INCGIS$18.4B$34.32$18.4B$87.6M-1.2%1.834.8%0.683/94/90/71/3F-Score 52/11
HORMEL FOODS CORP /DE/HRL$12.2B$22.09$12.1B$478.2M6.1%0.365.9%2.473/93/92/70/3F-Score 54/11
Lamb Weston Holdings, Inc.LW$7.7B$56.06$6.6B$290.0M15.9%2.018.9%1.422/94/90/70/3F-Score 73/11
SMITHFIELD FOODS INCSFD$7.6B$19.19$15.5B$987.0M14.5%0.298.3%2.976/93/93/73/3F-Score 68/11
CONAGRA BRANDS INC.CAG$7.0B$14.73$11.3B$1.9B-30.1%1.14-14.4%0.903/90/91/70/3F-Score 44/11